Taysha Gene Therapies, Inc. TSHA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$129.88M-19.2% | -$109M-9.1% | -$99.93M-7.8% | -$92.72M-6.9% | -$86.77M+2.8% | ||
| $1.09M+1.1% | $1.08M-0.5% | $1.09M-8.4% | $1.19M0.0% | $1.19M-3.4% | ||
| $15.55M+16.9% | $13.3M+2.4% | $12.99M-0.6% | $13.06M-1.1% | $13.2M+0.7% | ||
| -$111.95M-20.3% | -$93.09M-9.9% | -$84.68M-3.1% | -$82.13M+1.6% | -$83.45M-2.7% | ||
| $384K-48.0% | $738K+51.2% | $488K+17.6% | $415K-32.4% | $614K+63.3% | ||
| —— | —— | —— | —— | -$607K-61.4% | ||
| $275.35M+0.3% | $274.59M+22.0% | $225.03M+1.0% | $222.83M+189% | $77.01M0.0% | ||
| $175.56M-10.6% | $196.31M+26.6% | $155.07M+10.8% | $140.02M+1,995% | -$7.39M-50.6% | ||
| -$112.33M-19.7% | -$93.83M-10.2% | -$85.16M-3.2% | -$82.54M+1.8% | -$84.06M-3.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Taysha Gene Therapies, Inc.'s cash flow data come from?
- Every line is extracted from Taysha Gene Therapies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.